Streetbeat News

Regulatory

PTCT

PTC Therapeutics, Inc. (NASDAQ:PTCT) announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended the extension of the Evrysdi marketing authorization to include infants under two months of age in the EU. A final decision is expected from the European Commission later this year. Evrysdi is marketed by Roche and in the United States by Genentech, a member of the Roche Group.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 1:31 pm

AMZN

The Federal Trade Commission (FTC) has mandated Amazon (AMZN) to revise its deletion practices and enforce strict privacy measures to settle allegations of violating the Children's Online Privacy Protection Act Rule (COPPA Rule) and misleading parents and users of the Alexa voice assistant service about its data deletion practices.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 1:30 pm

SPY

USO

UAE Energy Minister has expressed no concerns about oil demand, but sees investment in capacity as the biggest challenge. He also mentioned that there is a mechanism to monitor Russian oil output, which will be developed with OPEC HQ. He believes that the current OPEC+ actions are sufficient for the oil market.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 1:23 pm

CORN

SOYB

SPY

VGK

WEAT

Russia's Deputy Foreign Minister has stated that there are ongoing negotiations regarding the free export of grain, but no agreements have been reached yet.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 1:21 pm

IXHL

Incannex Healthcare Limited (NASDAQ:IXHL) has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for IHL-42X, a treatment for obstructive sleep apnoea. The IND application includes comprehensive information on the safety and efficacy of IHL-42X, as well as details on the development, manufacturing, quality, and stability of the drug product. The application also outlines the clinical trial protocol for a multi-site phase 2/3 clinical trial investigating IHL-42X.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 1:10 pm

EVOK

Evoke Pharma Inc has been granted an extension until November 20, 2023, by Nasdaq to regain compliance, according to a SEC filing.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 1:04 pm

AAPL

AMD

NVDA

TSM

Taiwan Semiconductor Manufacturing Company Limited (TSMC) reported disappointing Q2 results and postponed the production launch at its U.S. plant to 2025. Q2 revenue dropped 10% to $15.68 billion and net income declined 23.3% to $5.8 billion. TSMC's largest client, Apple, also reported a sales drop for the second consecutive quarter. The delay in TSMC's U.S. plant production is a setback for Apple, Nvidia, and Advanced Micro Devices, who committed to source chips from the plant, and for the Biden administration's efforts to boost semiconductor manufacturing.

Portfolio Pulse from Upwallstreet

July 21, 2023 | 12:34 pm

DWAC

FRTX

RDHL

Digital World (DWAC) has reached a settlement with the SEC, which will allow for a review of its Form S-4 Registration Statement. Fresh Tracks (FRTX) has announced an $8.25 million buyout of its right to receive future Sofpironium Bromide payments from Botanix. RedHill (RDHL) has announced additional U.S. government funding for Opaganib Nuclear Countermeasure Development.

Portfolio Pulse from ryanfaloona@benzinga.com

July 21, 2023 | 12:31 pm

SGBX

Safe & Green Holdings (SGBX) has regained compliance with Nasdaq's continued listing requirements, thereby avoiding potential delisting.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:31 pm

DWAC

Digital World Acquisition Corp (DWAC) has reached a settlement with the SEC, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:18 pm